GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » EV-to-EBIT

Pro Medicus (ASX:PME) EV-to-EBIT : 124.51 (As of May. 12, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pro Medicus's Enterprise Value is A$11,893.5 Mil. Pro Medicus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$95.5 Mil. Therefore, Pro Medicus's EV-to-EBIT for today is 124.51.

The historical rank and industry rank for Pro Medicus's EV-to-EBIT or its related term are showing as below:

ASX:PME' s EV-to-EBIT Range Over the Past 10 Years
Min: -58.12   Med: 86.42   Max: 648.72
Current: 124.51

During the past 13 years, the highest EV-to-EBIT of Pro Medicus was 648.72. The lowest was -58.12. And the median was 86.42.

ASX:PME's EV-to-EBIT is ranked worse than
96.73% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.24 vs ASX:PME: 124.51

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Pro Medicus's Enterprise Value for the quarter that ended in Dec. 2023 was A$9,878.9 Mil. Pro Medicus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$95.5 Mil. Pro Medicus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 0.97%.


Pro Medicus EV-to-EBIT Historical Data

The historical data trend for Pro Medicus's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus EV-to-EBIT Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.74 90.23 143.15 69.28 80.41

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 69.28 - 80.41 -

Competitive Comparison of Pro Medicus's EV-to-EBIT

For the Health Information Services subindustry, Pro Medicus's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pro Medicus's EV-to-EBIT falls into.



Pro Medicus EV-to-EBIT Calculation

Pro Medicus's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=11893.546/95.52
=124.51

Pro Medicus's current Enterprise Value is A$11,893.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pro Medicus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$95.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (ASX:PME) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Pro Medicus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=95.52/9878.94365
=0.97 %

Pro Medicus's Enterprise Value for the quarter that ended in Dec. 2023 was A$9,878.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pro Medicus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$95.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Pro Medicus's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (ASX:PME) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.